Ocugen Expands COVAXIN™ Commercialization Rights to Include Canada
Ocugen, Inc. and Bharat Biotech today announced that they have entered into an amendment to their Co ...
Read more
Tag: Bharat Biotech
DCGI approves Phase II/III clinical trial of COVAXIN in the age group of 2 to 18 Years
The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, ...
Read more
COVAXIN® Demonstrates overall Interim Clinical Efficacy of 78% and 100% efficacy against Severe COVID-19 disease
Bharat Biotech announced phase 3 interim analysis results of COVAXIN®. The second interim analysis is based ...
Read more
Government of India provides grant of 65 Cr to Bharat Biotech for increase in the capacity of vaccine production
Under Atmanirbhar Bharat 3.0 Mission COVID Suraksha was announced by the Government of India, to accelerate ...
Read more